Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review
- PMID: 20697963
- PMCID: PMC3024099
- DOI: 10.1007/s11606-010-1472-0
Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review
Abstract
Background: Malignant pleural effusions (MPE) are a frequent cause of dyspnea and discomfort at the end of cancer patients' lives. The tunneled indwelling pleural catheter (TIPC) was approved by the FDA in 1997 and has been investigated as a treatment for MPE.
Objective: To systematically review published data on the efficacy and safety of the TIPC for treatment of MPE.
Design: We searched the MEDLINE, EMBASE, and ISI Web of Science databases to identify studies published through October 2009 that reported outcomes in adult patients with MPE treated with a TIPC. Data were aggregated using summary statistics when outcomes were described in the same way among multiple primary studies.
Main measures: Symptomatic improvement and complications associated with use of the TIPC.
Key results: Nineteen studies with a total of 1,370 patients met criteria for inclusion in the review. Only one randomized study directly compared the TIPC with the current gold standard treatment, pleurodesis. All other studies were case series. Symptomatic improvement was reported in 628/657 patients (95.6%). Quality of life measurements were infrequently reported. Spontaneous pleurodesis occurred in 430/943 patients (45.6%). Serious complications were rare and included empyema in 33/1168 patients (2.8%), pneumothorax requiring a chest tube in 3/51 (5.9%), and unspecified pneumothorax in 17/439 (3.9%). Minor complications included cellulitis in 32/935 (3.4%), obstruction/clogging in 33/895 (3.7%) and unspecified malfunction of the catheter in 11/121 (9.1%). The use of the TIPC was without complication in 517/591 patients (87.5%).
Conclusions: Based on low-quality evidence in the form of case series, the TIPC may improve symptoms for patients with MPE and does not appear to be associated with major complications. Prospective randomized studies comparing the TIPC to pleurodesis are needed before the TIPC can be definitively recommended as a first-line treatment of MPE.
Figures
Similar articles
-
Pleurodesis for malignant pleural effusions.Cochrane Database Syst Rev. 2004;(1):CD002916. doi: 10.1002/14651858.CD002916.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2013 Nov 20;(11):CD002916. doi: 10.1002/14651858.CD002916.pub3. PMID: 14973997 Updated.
-
Interventions for palliative symptom control in COVID-19 patients.Cochrane Database Syst Rev. 2021 Aug 23;8(8):CD015061. doi: 10.1002/14651858.CD015061. Cochrane Database Syst Rev. 2021. PMID: 34425019 Free PMC article.
-
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2. Cochrane Database Syst Rev. 2020. PMID: 33075160 Free PMC article.
-
Washout policies in long-term indwelling urinary catheterisation in adults.Cochrane Database Syst Rev. 2017 Mar 6;3(3):CD004012. doi: 10.1002/14651858.CD004012.pub5. Cochrane Database Syst Rev. 2017. PMID: 28262925 Free PMC article.
-
Surgical versus non-surgical management for pleural empyema.Cochrane Database Syst Rev. 2017 Mar 17;3(3):CD010651. doi: 10.1002/14651858.CD010651.pub2. Cochrane Database Syst Rev. 2017. PMID: 28304084 Free PMC article.
Cited by
-
Management of malignant pleural effusion.Lung. 2013 Apr;191(2):165-75. doi: 10.1007/s00408-012-9445-1. Epub 2013 Jan 13. Lung. 2013. PMID: 23315213 Review.
-
Intrapleural infusion of tumor cell-derived microparticles packaging methotrexate or saline combined with pemetrexed-cisplatin chemotherapy for the treatment of malignant pleural effusion in advanced non-squamous non-small cell lung cancer: A double-blind, randomized, placebo-controlled study.Front Immunol. 2022 Oct 5;13:1002938. doi: 10.3389/fimmu.2022.1002938. eCollection 2022. Front Immunol. 2022. PMID: 36275698 Free PMC article. Clinical Trial.
-
Indwelling pleural catheters for malignancy-associated pleural effusion: report on a single centre's ten years of experience.BMC Pulm Med. 2019 Dec 2;19(1):232. doi: 10.1186/s12890-019-1002-8. BMC Pulm Med. 2019. PMID: 31791305 Free PMC article.
-
Noninvasive Management of Fractured Indwelling Tunneled Pleural Catheter Valve.Case Rep Pulmonol. 2022 Aug 13;2022:2541285. doi: 10.1155/2022/2541285. eCollection 2022. Case Rep Pulmonol. 2022. PMID: 35996613 Free PMC article.
-
Safety and Performance Characteristics of Outpatient Medical Thoracoscopy and Indwelling Pleural Catheter Insertion for Evaluation and Diagnosis of Pleural Disease at a Tertiary Center in Canada.Can Respir J. 2017;2017:9345324. doi: 10.1155/2017/9345324. Epub 2017 Aug 30. Can Respir J. 2017. PMID: 28951662 Free PMC article.
References
-
- Antony VB, Loddenkemper R, Astoul P, et al. Management of malignant pleural effusions. American Journal of Respiratory and Critical Care Medicine. 2000;162:1987–2001. - PubMed
-
- Michaud G, Barclay P, Tremblay A. Tunneled pleural catheters for palliation of malignant pleural effusions. Journal of Bronchology. 2005;12:245–8. doi: 10.1097/01.lab.0000185782.99433.02. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous